CLINICAL_TRIALS
research
· 2011-08-09
Clinical Trial Update: The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Summary
An update on the molecular biology of paroxysmal nocturnal hemoglobinuria (PNH) from a completed University of Utah clinical trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Utah | Conditions: Hemoglobinuria, Paroxysmal | Status: COMPLETED